Zostavax Encephalitis Class Action Lawsuit
Zostavax, a vaccine used to protect against herpes zoster (shingles) in people aged 50 years and older, has been found to be ineffective, and instead actually increases the risk of serious side effects including encephalitis, an inflammation of the brain...